---
layout: post
title: "Electronic Study Data Submission; Data Standards; Support and Requirement Begin for Study Data Tabulation Model Version 1.8 With Standard for Exchange of Nonclinical Data Implementation Guide-Animal Rule Version 1.0"
date: 2026-02-05 19:08:54 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2020-04898
original_published: 2020-03-11 00:00:00 +0000
significance: 8.00
---

# Electronic Study Data Submission; Data Standards; Support and Requirement Begin for Study Data Tabulation Model Version 1.8 With Standard for Exchange of Nonclinical Data Implementation Guide-Animal Rule Version 1.0

**Published:** February 05, 2026 19:08 UTC
**Source:** Federal Register
**Original Published:** March 11, 2020 00:00 UTC
**Document Number:** 2020-04898

## Summary

The Food and Drug Administration (FDA or Agency) Center for Drug Evaluation and Research (CDER) is announcing that FDA will begin supporting the Clinical Data Interchange Standards Consortium (CDISC) for Study Data Tabulation Model version 1.8 (SDTM v1.8), and CDISC Standard for Exchange of Nonclinical Data Implementation Guide--Animal Rule version 1.0 (SENDIG-AR v1.0) on March 15, 2020, and that these new standards will be required in submissions to FDA effective March 15, 2022. An update will be made to the FDA Data Standards Catalog (Catalog) to reflect these changes.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2020/03/11/2020-04898/electronic-study-data-submission-data-standards-support-and-requirement-begin-for-study-data)
- API: https://www.federalregister.gov/api/v1/documents/2020-04898

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
